Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphoma.
Watson P, Wood KM, Lodge A, McIntosh GG, Milton I, Piggott NH, Proctor SJ, Taylor PR, Smith S, Jack F, Bell H, Steward M, Anderson JJ, Horne CH, Angus B. Watson P, et al. Among authors: jack f. Histopathology. 2000 Feb;36(2):145-50. doi: 10.1046/j.1365-2559.2000.00813.x. Histopathology. 2000. PMID: 10672059
Hodgkin's disease in the elderly: a population-based study.
Stark GL, Wood KM, Jack F, Angus B, Proctor SJ, Taylor PR; Northern Region Lymphoma Group. Stark GL, et al. Among authors: jack f. Br J Haematol. 2002 Nov;119(2):432-40. doi: 10.1046/j.1365-2141.2002.03815.x. Br J Haematol. 2002. PMID: 12406082 Free article.
Prognostic score for Hodgkin's disease.
Jack FR, Angus B, Taylor PR. Jack FR, et al. N Engl J Med. 1999 Apr 22;340(16):1288-9; author reply 1289-90. doi: 10.1056/nejm199904223401615. N Engl J Med. 1999. PMID: 10215496 No abstract available.
The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.
Burnett AK, Milligan D, Goldstone A, Prentice A, McMullin MF, Dennis M, Sellwood E, Pallis M, Russell N, Hills RK, Wheatley K; United Kingdom National Cancer Research Institute Haematological Oncology Study Group. Burnett AK, et al. Br J Haematol. 2009 May;145(3):318-32. doi: 10.1111/j.1365-2141.2009.07604.x. Epub 2009 Mar 8. Br J Haematol. 2009. PMID: 19291085 Free article. Clinical Trial.
A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial.
Dennis M, Burnett A, Hills R, Thomas I, Ariti C, Severinsen MT, Hemmaway C, Greaves P, Clark RE, Copland M, Russell N; National Cancer Research Institute (NCRI) acute myeloid leukaemia (AML) Working Group. Dennis M, et al. Br J Haematol. 2021 Jul;194(2):298-308. doi: 10.1111/bjh.17501. Epub 2021 May 7. Br J Haematol. 2021. PMID: 33961292 Clinical Trial.
41 results